BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 16836306)

  • 1. Ozonolysis applications in drug synthesis.
    Van Ornum SG; Champeau RM; Pariza R
    Chem Rev; 2006 Jul; 106(7):2990-3001. PubMed ID: 16836306
    [No Abstract]   [Full Text] [Related]  

  • 2. Asymmetric synthesis of active pharmaceutical ingredients.
    Farina V; Reeves JT; Senanayake CH; Song JJ
    Chem Rev; 2006 Jul; 106(7):2734-93. PubMed ID: 16836298
    [No Abstract]   [Full Text] [Related]  

  • 3. Boron reagents in process chemistry: Excellent tools for selective reductions.
    Burkhardt ER; Matos K
    Chem Rev; 2006 Jul; 106(7):2617-50. PubMed ID: 16836295
    [No Abstract]   [Full Text] [Related]  

  • 4. The impact of microwave synthesis on drug discovery.
    Kappe CO; Dallinger D
    Nat Rev Drug Discov; 2006 Jan; 5(1):51-63. PubMed ID: 16374514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-scale oxidations in the pharmaceutical industry.
    Caron S; Dugger RW; Ruggeri SG; Ragan JA; Ripin DH
    Chem Rev; 2006 Jul; 106(7):2943-89. PubMed ID: 16836305
    [No Abstract]   [Full Text] [Related]  

  • 6. Organolithium reagents in pharmaceutical asymmetric processes.
    Wu G; Huang M
    Chem Rev; 2006 Jul; 106(7):2596-616. PubMed ID: 16836294
    [No Abstract]   [Full Text] [Related]  

  • 7. Accelerating the drug-discovery process: new tools and technologies available to medicinal chemists.
    Raveglia LF; Giardina GA
    Future Med Chem; 2009 Sep; 1(6):1019-23. PubMed ID: 21425990
    [No Abstract]   [Full Text] [Related]  

  • 8. Critical assessment of pharmaceutical processes--A rationale for changing the synthetic route.
    Butters M; Catterick D; Craig A; Curzons A; Dale D; Gillmore A; Green SP; Marziano I; Sherlock JP; White W
    Chem Rev; 2006 Jul; 106(7):3002-27. PubMed ID: 16836307
    [No Abstract]   [Full Text] [Related]  

  • 9. March of the synthesis machines.
    Sanderson K
    Nat Rev Drug Discov; 2015 May; 14(5):299-300. PubMed ID: 25924572
    [No Abstract]   [Full Text] [Related]  

  • 10. Stereoselective heterocycle synthesis through oxidative carbon-hydrogen bond activation.
    Liu L; Floreancig PE
    Curr Opin Drug Discov Devel; 2010; 13(6):733-47. PubMed ID: 21061234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enabling continuous-flow chemistry in microstructured devices for pharmaceutical and fine-chemical production.
    Kockmann N; Gottsponer M; Zimmermann B; Roberge DM
    Chemistry; 2008; 14(25):7470-7. PubMed ID: 18613163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective growth of a stable drug polymorph by suppressing the nucleation of corresponding metastable polymorphs.
    Cox JR; Ferris LA; Thalladi VR
    Angew Chem Int Ed Engl; 2007; 46(23):4333-6. PubMed ID: 17476660
    [No Abstract]   [Full Text] [Related]  

  • 13. Practical methodologies for the synthesis of indoles.
    Humphrey GR; Kuethe JT
    Chem Rev; 2006 Jul; 106(7):2875-911. PubMed ID: 16836303
    [No Abstract]   [Full Text] [Related]  

  • 14. Expanding the scope of crystal form evaluation in pharmaceutical science.
    Peterson ML; Hickey MB; Zaworotko MJ; Almarsson O
    J Pharm Pharm Sci; 2006; 9(3):317-26. PubMed ID: 17207415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diversity-oriented synthesis.
    Spandl RJ; Díaz-Gavilán M; O'Connell KM; Thomas GL; Spring DR
    Chem Rec; 2008; 8(3):129-42. PubMed ID: 18563806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular apple peels.
    Garric J; Léger JM; Huc I
    Angew Chem Int Ed Engl; 2005 Mar; 44(13):1954-8. PubMed ID: 15726563
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of drug intermediates by using direct organocatalytic multi-component reactions.
    Ramachary DB; Kishor M; Reddy GB
    Org Biomol Chem; 2006 May; 4(9):1641-6. PubMed ID: 16633553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ways to search out new drugs via synthesis].
    Turkevich NM
    Farm Zh; 1977; (3):27-36. PubMed ID: 881018
    [No Abstract]   [Full Text] [Related]  

  • 19. Designer discodermolide segments via ozonolysis of vinyl phosphonates.
    Mollat du Jourdin X; Noshi M; Fuchs PL
    Org Lett; 2009 Feb; 11(3):543-6. PubMed ID: 19117490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expediting drug discovery: recent advances in fast medicinal chemistry--optimization of hits and leads.
    Edwards PJ; Allart B; Andrews MJ; Clase JA; Menet C
    Curr Opin Drug Discov Devel; 2006 Jul; 9(4):425-44. PubMed ID: 16889227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.